Zevra Therapeutics
Denmark - FrederiksbergBiotechnology
Focus: Zevra Therapeutics is a Denmark-based biotech company focused on rare disease treatment through modifications of existing drugs. The company operates at mid-cap biotech scale with a marketed product and a growing clinical pipeline.
Profile data last refreshed 7h ago · AI intelligence enriched 2w ago
Open Jobs
10-2 this month
Stable — net -2 jobs in 30d
2 added, 4 removed. Backfill posture.
Should You Work at Zevra Therapeutics?
AI assessmentBest suited for Medical Affairs or regulatory professionals seeking rare disease expertise and commercial-stage stability; risky for R&D-focused careers due to limited pipeline depth and opaque finances.
Why Work Here
- Rare disease focus provides meaningful impact on underserved patient populations with lower commercial saturation than mainstream indications
Data completeness
6/9 — Partial
Company HealthStrong
Pipeline
Mid-stage
2 Phase 3+
LOE Risk
1 in 5yr
APADAZ
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
Peak4.8yr
Company's sole marketed revenue generator; faces patent cliff in 2031 requiring pipeline maturation within 7 years.
Help build intelligence for Zevra Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.